The Ministry of Ayush has collaborated with the U.K.’s London School of Hygiene and Tropical Medicine (LSHTM) to conduct a study on ‘Ashwagandha’ for promoting recovery from COVID-19.
- The All India Institute of Ayurveda (AIIA), an autonomous body under the Ministry of Ayush, and the LSHTM recently signed a Memorandum of Understanding (MoU) to conduct clinical trials of ‘Ashwagandha’ on 2,000 participants in three U.K. cities — Leicester, Birmingham and London (Southall and Wembley).
- ‘Ashwagandha’ (Withania somnifera) is commonly known as ‘Indian winter cherry’.
- It is a traditional Indian herb that boosts energy, reduces stress and makes the immune system stronger.
- It is an easily accessible, over-the-counter nutritional supplement in the U.K. and has a proven safety profile. The positive effects of ‘Ashwagandha’ have been observed in long COVID-19, which is a multi-system disease with no evidence of its effective treatment or management.
- It added that the successful completion of the trial could be a major breakthrough and could give scientific validity to India’s traditional medicinal system.
(Source: The Hindu)
